Filed Pursuant to Rule 424(b)(3)
Registration No. 333-222231
NUVEEN GLOBAL CITIES REIT, INC.
SUPPLEMENT NO. 11 DATED FEBRUARY 14, 2020
TO THE PROSPECTUS DATED APRIL 12, 2019
This prospectus supplement (the “Supplement”) is part of and should be read in conjunction with the prospectus of Nuveen Global Cities REIT, Inc. dated April 12, 2019 (the “Prospectus”), Supplement No. 1 dated July 10, 2019, Supplement No. 2 dated July 16, 2019, Supplement No. 3 dated August 16, 2019, Supplement No. 4 dated September 16, 2019, Supplement No. 5 dated October 17, 2019, Supplement No. 6 dated November 15, 2019, Supplement No. 7 dated December 13, 2019, Supplement No. 8 dated January 15, 2020, Supplement No. 9 dated January 21, 2020 and Supplement No. 10 dated February 4, 2020. Unless otherwise defined herein, capitalized terms used in this Supplement shall have the same meanings as in the Prospectus.
The purposes of this Supplement are as follows:
| • | | to disclose our acquisition of an additional property; |
| • | | to disclose the transaction price for each class of our common stock as of March 1, 2020; |
| • | | to disclose the calculation of our January 31, 2020 net asset value (“NAV”) per share for each class of our common stock; and |
| • | | to provide an update on our initial public offering. |
Property Acquisition
On December 21, 2019, we completed the acquisition of the property known as 9725 Datapoint, a medical office property located in San Antonio, Texas, from an unaffiliated third party for approximately $36.5 million, including transaction costs. We funded the acquisition with cash on hand. The property is 100% leased to three tenants with a weighted average lease term of 12.4 years at the time of acquisition. The acquisition represents the first medical office property in our portfolio.
March 1, 2020 Transaction Price
The transaction price for each share class of our common stock for subscriptions accepted as of March 1, 2020 (and repurchases as of February 29, 2020) is as follows:
| | | | |
| | Transaction Price (per share) | |
Class T | | $ | 10.70 | |
Class S | | | 10.66 | |
Class D | | | 10.79 | |
Class I | | | 10.81 | |
The transaction price for our Class T, Class S, Class D and Class I shares is equal to such class’s NAV per share as of January 31, 2020. A detailed presentation of the NAV per share is set forth below.
The purchase price of our common stock for each share class equals the transaction price of such class, plus applicable upfront selling commissions and dealer manager fees.
VGN-NREIT2-0220P